FDA Determines Regulatory Review Period for ATS Open Pivot Bileaf Heart Valve Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the ATS Open Pivot Bileaf Heart Valve, a medical device, in accordance with federal regulations, following a patent extension application submitted to the US Department of Commerce.